Obituaries
PGe
PG Store
Archives
Classifieds
Classified
Events
Jobs
Real Estate
Legal Notices
Pets
MENU
SUBSCRIBE
LOGIN
REGISTER
LOG OUT
MY PROFILE
Home
News
Local
Sports
Opinion
A&E
Life
Business
Contact Us
NEWSLETTERS
MENU
ACCOUNT
Subscribe
Login
Register
Log out
My Profile
Subscriber Services
Search
SECTIONS
HOME
Homepage
This Just In
Chats
Weather
Traffic
Event Guide
PG Store
PGe
Video
Photos
The Digs
RSS Feeds
NEWS
News Home
COVID-19
World
Nation
State
Obituaries
News Obituaries
Politics
Education
Portfolio
Science
Health & Wellness
Environment
Aging Edge
Transportation
Faith & Religion
Crimes & Courts
Social Services
LOCAL
Local Home
Region
City
North
East
West
South
Washington
Westmoreland
The Neighborhood
Obituaries
Classifieds
Legal Notices
Real Estate
SPORTS
Sports Home
Steelers
Penguins
Pirates
Sports Columns
Gene Collier
Ron Cook
Joe Starkey
Paul Zeise
High School Sports
College Sports
Pitt
Penn State
WVU
NCAA
NFL
MLB
NBA
NHL
North Shore Drive Podcast
OPINION
Opinion Home
Editorials
Letters
Op-Ed Columns
PG Columnists
Insight
A&E
A&E Home
Celebrities
Movies
TV & Radio
Music
Concert Listings
Theatre & Dance
Art & Architecture
Books
Events
LIFE
Life Home
Food
Buying Here
Homes & Gardens
Style & Fashion
Travel
Restaurants
Seen
goodness
Random Acts of Kindness
Pets
Beer Me
Outdoors
Holidays
BUSINESS
Business Home
Your Money
Wheels
Workzone
Business Health
Tech News
Building PGH
Powersource
Business / Law
Top Workplaces
Business of Pittsburgh
Consumer Alerts
OTHER
PGe
NEWSLETTERS
PG STORE
ARCHIVES
CLASSIFIEDS
OBITUARIES
JOBS
LEGAL NOTICES
REAL ESTATE
CLASSIFIEDS
EVENTS
PETS
CONTACT US / FAQ
CONTACT US
ADVERTISING
CAREER OPPORTUNITIES
Recent Quotes
View Full List
My Watchlist
Create Watchlist
Indicators
DJI
Nasdaq Composite
SPX
Gold
Crude Oil
Markets
Stocks
ETFs
Tools
Markets:
Overview
News
Currencies
International
Treasuries
GH Research PLC - Ordinary Shares
(NQ:
GHRS
)
28.07
UNCHANGED
Streaming Delayed Price
Updated: 4:00 PM EDT, Jul 31, 2026
Add to My Watchlist
Quote
Overview
Detailed Quote
Charting
Historical Prices
News
All News
News Headlines
Press Releases
Research
Quarterly Reports
Insider Filings
Other Filings
All News about GH Research PLC - Ordinary Shares
< Previous
1
2
...
7
8
9
10
11
12
13
14
15
...
19
20
Next >
GH Research, Seelos Therapeutics Among Top Psychedelic Movers Of Today
↗
November 15, 2022
Via
Benzinga
Clinical Stage Psychedelic Stock Index Up 6%; Therapy Clinic Stocks Down 8%
↗
November 14, 2022
We highlight the performance of our Psychedelic Drug Stocks Index and the 6 psychedelic stocks that research the treatment of a variety of mental illnesses based on the use of different psychedelic...
Via
Talk Markets
Compass Pathways, Mind Medicine Among Top Psychedelic Movers Of Today
↗
November 10, 2022
GAINERS: Compass Pathways (NASDAQ:CMPS) shares closed up 12.17% at $10.05
Via
Benzinga
GH Research Reports Third Quarter 2022 Financial Results and Provides Business Updates
November 10, 2022
From
GH Research PLC
Via
GlobeNewswire
Seelos Therapeutics, GH Research Among Top Psychedelic Movers Of Today
↗
November 09, 2022
GAINERS: GH Research (NASDAQ:GHRS) shares closed up 7.91% at $9.96 LOSERS:
Via
Benzinga
Psychedelic Stock Gainers And Losers From November 8, 2022
↗
November 08, 2022
GAINERS: Small Pharma (OTC:DMTTF) shares closed up 3.85% at $0.14
Via
Benzinga
The Psychedelic Drug Stocks Index Continued To Plummet Last Week
↗
November 07, 2022
In total, the Psychedelic Drug Stock Index went down 5.8% last week and is now down 64.9% YTD.
Via
Talk Markets
Compass Pathways, Allied Among Top Psychedelic Movers Of Today
↗
November 07, 2022
GAINERS: Allied (OTC:ALID) shares closed up 4.10% at $0.44
Via
Benzinga
Psychedelic Stock Gainers And Losers From November 3, 2022
↗
November 03, 2022
GAINERS: Compass Pathways (NASDAQ:CMPS) shares closed up 4.80% at $10.27
Via
Benzinga
Compass Pathways, Small Pharma Among Top Psychedelic Movers Of Today
↗
November 02, 2022
GAINERS: GH Research (NASDAQ:GHRS) shares closed up 3.90% at $10.39 LOSERS:
Via
Benzinga
October Recap: Major Psychedelic Drug Stocks Declined 9.9%
↗
October 27, 2022
In total, thePsychedelic Drug Stock Index went down 9.9% in September and is now down 64.7% YTD.
Via
Talk Markets
Revive Therapeutics, Small Pharma Among Top Psychedelic Movers Of Today
↗
October 27, 2022
GAINERS: Seelos Therapeutics (NASDAQ:SEEL) shares closed up 3.00% at $0.87
Via
Benzinga
Psychedelic Stock Gainers And Losers From October 26, 2022
↗
October 26, 2022
GAINERS: Revive Therapeutics (OTC:RVVTF) shares closed up 5.39% at $0.18
Via
Benzinga
Psychedelic Stock Gainers And Losers From October 25, 2022
↗
October 25, 2022
GAINERS: Compass Pathways (NASDAQ:CMPS) shares closed up 6.24% at $10.39
Via
Benzinga
Cannabis Category Performances Ranged From +14.4% To -4.6% This Past Week
↗
October 24, 2022
The 5 categories in the cannabis sector perform quite differently week to week. Below is a summary of how each category performed last week, in descending order and since the end of September and since...
Via
Talk Markets
Major Psychedelic Stock Downward Trend Continues
↗
October 24, 2022
The 8 constituents of our Psychedelic Drug Stocks Index continue to collectively show poor performance, down 4.6% more last week and now down 45.5% since the end of August.
Via
Talk Markets
Allied, Small Pharma Among Top Psychedelic Movers Of Today
↗
October 21, 2022
GAINERS: Allied (OTC:ALID) shares closed up 10.21% at $0.53
Via
Benzinga
Psychedelic Stock Gainers And Losers From October 18, 2022
↗
October 18, 2022
GAINERS: Small Pharma (OTC:DMTTF) shares closed up 15.76% at $0.14
Via
Benzinga
Psychedelic Stock Gainers And Losers From October 17, 2022
↗
October 17, 2022
GAINERS: Biomind Labs (OTC:BMNDF) shares closed up 38.18% at $1.52
Via
Benzinga
Small Pharma, Cybin Among Top Psychedelic Movers Of Today
↗
October 14, 2022
GAINERS: Small Pharma (OTC:DMTTF) shares closed up 9.12% at $0.12
Via
Benzinga
Psychedelic Stock Gainers And Losers From October 12, 2022
↗
October 12, 2022
GAINERS: Allied (OTC:ALID) shares closed up 48.05% at $0.48
Via
Benzinga
Numinus Wellness, Small Pharma Among Top Psychedelic Movers Of Today
↗
October 11, 2022
GAINERS: Small Pharma (OTC:DMTTF) shares closed up 7.61% at $0.12
Via
Benzinga
Psychedelic Stock Gainers And Losers From October 10, 2022
↗
October 10, 2022
GAINERS: Cybin (AMEX:CYBN) shares closed up 5.51% at $0.63 LOSERS:
Via
Benzinga
Psychedelic Drug Stocks Index Up Slightly This Week
↗
October 08, 2022
There are 8 stocks in the munKNEE Psychedelic Drug Stocks Index and this article reveals how its constituents performed this week, in descending order, since the end of August and YTD.
Via
Talk Markets
Psychedelic Stock Gainers And Losers From October 6, 2022
↗
October 06, 2022
GAINERS: Revive Therapeutics (OTC:RVVTF) shares closed up 45.41% at $0.22
Via
Benzinga
Allied, GH Research Among Top Psychedelic Movers Of Today
↗
October 04, 2022
GAINERS: Allied (OTC:ALID) shares closed up 31.58% at $0.60
Via
Benzinga
Cybin, GH Research Among Top Psychedelic Movers Of Today
↗
October 03, 2022
GAINERS: Cybin (AMEX:CYBN) shares closed up 20.50% at $0.58
Via
Benzinga
September Cannabis Category Performances Ranged From -6.3% To -39.0%
↗
October 03, 2022
The performances of the 5 cannabis categories ranged from -6.3% to -39.0% in September, and are now -13.6% to -67.0%, YTD, depending on the category. The S&P 500, in comparison, was -8.6% in September...
Via
Talk Markets
Major Psychedelic Stocks Continued To Decline In September
↗
October 02, 2022
There are 8 stocks in the munKNEE Psychedelic Compounds-Based Drug Stocks Index. Most - but interestingly not all - were down for the week and/or the month.
Via
Talk Markets
Allied, Revive Therapeutics Among Top Psychedelic Movers Of Today
↗
September 30, 2022
GAINERS: Cybin (AMEX:CYBN) shares closed up 2.08% at $0.49
Via
Benzinga
< Previous
1
2
...
7
8
9
10
11
12
13
14
15
...
19
20
Next >
Stock Quote API & Stock News API supplied by
www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the
Privacy Policy
and
Terms Of Service
.
© 2025 FinancialContent. All rights reserved.
TOP
Email a Story
Your e-mail:
Friends e-mail:
Submit